Understanding compliance issues for daily self-injectable treatment in ambulatory care settings
Authors Meryl Brod, Matthew Rousculp, Ann Cameron
Published 6 April 2008 Volume 2008:2 Pages 129—136
Meryl Brod1, Matthew Rousculp2, Ann Cameron2
1The Brod Group, Mill Valley, California, USA; 2Health Outcomes, Eli Lilly and Company, Indianapolis, Indiana, USA
Background: The challenge of understanding factors influencing compliance with injectable treatments is critical as injectable biologics/medications become more common.
Objective: Understanding compliance issues for long term self-injectable treatments, using a chronic condition (osteoporosis) as a model.
Research design: A qualitative study to generate hypotheses regarding compliance issues for self-injectable treatments. Semi-structured interview guides were developed and data collected from patients and clinical experts. Findings were analyzed for common themes and a conceptual model of the compliance impact of self-injectable treatments generated.
Subjects: Six physicians (Rheumatology, Internal Medicine, and Endocrinology) and 22 patients (14% never began treatment, 23% had filled at least one prescription but discontinued treatment, and 63% were currently on treatment) were interviewed.
Results: Physician and patient factors influenced the compliance process at four distinct timepoints: pre-treatment, time treatment recommended, short-term, and long-term. Physician factors that influenced patients’ persistence were knowledge about treatment, patient-training resources, and clinical profile/efficacy evaluations. For patients, motivation level, physician message, and clinical profile were key. Logistical issues, minor side effects and injection site issues influenced adherence but not persistence.
Conclusions: Compliance is a multifactorial, dynamic process. Both physician and patient factors influence compliance at different points in the process.
Keywords: osteoporosis, self-injectable treatments, compliance, persistence, adherence
Readers of this article also read:
Paul J Mills, Joel E Dimsdale, Suzi Hong, Geoffrey Van Den Brande, Laura Redwine, et al
Published Date: 11 November 2008
EAG Joosten, GH de Weert, T Sensky, CPF van der Staak, CAJ de Jong
Published Date: 14 October 2008
Anne-Marie Landtblom, Cecilia Lang, Gullvi Flensner
Published Date: 9 September 2008
Analgesic efficacy of zoledronic acid and its effect on functional status of prostate cancer patients with metastasis
Rafael Gálvez, Victoria Ribera, José Ramón González-Escalada, Alicia Souto, María Luz Cánovas, et al
Published Date: 20 August 2008
Patient recruitment for clinical trials on traditional Chinese medicine: Challenges, barriers, and strategies
Cheng King-Fai, Leung Ping-Chung, Wong Lai-Yi, Fong Yuet-Shim
Published Date: 11 August 2008
Marinke Westerterp, Henderik L van Westreenen, Marije Deutekom, Jaap Stoker, Paul Fockens, et al
Published Date: 30 April 2008
Published Date: 28 April 2008
Nahid Ahmadian Yazdi, Sedigheh Sadat Tavafian, Ali Emadzadeh, Anooshirvan Kazemnejad, Fazlollah Ghofranipour
Published Date: 8 April 2008
Rebecca A O’Brien, Parisa Aslani, Maria A Ciccia, Jo-anne E Brien
Published Date: 20 March 2008
Published Date: 5 February 2008